Gastric tumor-initiating CD44+ cells and epithelial-mesenchymal transition are inhibited by γ-secretase inhibitor DAPT

被引:19
作者
Li, Lu-Chun [1 ]
Wang, Dong-Lin [1 ]
Wu, Yong-Zhong [2 ]
Nian, Wei-Qi [3 ]
Wu, Zhi-Juan [1 ]
Li, Yan [1 ]
Ma, Hui-Wen [1 ]
Shao, Jiang-He [1 ]
机构
[1] Chongqing Canc Inst, Dept Oncol, Chongqing 400030, Peoples R China
[2] Chongqing Canc Inst, Dept Radiotherapy, Chongqing 400030, Peoples R China
[3] Chongqing Canc Inst, Dept Galactophore, Chongqing 400030, Peoples R China
基金
中国国家自然科学基金;
关键词
Notch1; gastric cancer; cancer stem cells; epithelial-mesenchymal transition; CANCER STEM-CELLS; NOTCH; PATHWAY;
D O I
10.3892/ol.2015.3727
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
It has been proposed that the Notch signaling pathway may serve a pivotal role in cellular differentiation, proliferation and apoptosis. However, the function of Notch signaling in gastric cancer stem cells (GCSCs) is largely unknown. The present study aimed to delineate the role of the Notch1 pathway in GCSCs and during epithelial-mesenchymal transition (EMT). Flow cytometry was used to isolate CD44(+) cells from the human gastric cancer cell line, MKN45. CD44(+) cells displayed the characteristics of CSCs and exhibited higher Notch1 expression compared with CD44-cells. To investigate the role of the Notch1 pathway in GCSCs, CD44(+) cells were treated with the.-secretase inhibitor DAPT. DAPT treatment inhibited the expression of the Notch1 downstream target Hes1 and EMT markers, suppressed the properties of CSCs and impaired the invasion and proliferation capabilities of CD44(+) cells. In addition, intraperitoneal treatment with DAPT effectively inhibited the growth of CD44(+) cell xenograft tumors. The present study indicated that CD44(+) GCSCs possess the characteristics of CSCs and that the Notch1 pathway serves a critical role in the maintenance of CSCs and EMT.
引用
收藏
页码:3293 / 3299
页数:7
相关论文
共 33 条
[11]   Cancer spheres from gastric cancer patients provide an ideal model system for cancer stem cell research [J].
Han, Myoung-Eun ;
Jeon, Tae-Yong ;
Hwang, Sun-Hwi ;
Lee, Young-Suk ;
Kim, Hyun-Jung ;
Shim, Hye-Eun ;
Yoon, Sik ;
Baek, Sun-Yong ;
Kim, Bong-Seon ;
Kang, Chi-Dug ;
Oh, Sae-Ock .
CELLULAR AND MOLECULAR LIFE SCIENCES, 2011, 68 (21) :3589-3605
[12]   Pancreatic cancer stem cells: new understanding of tumorigenesis, clinical implications [J].
Ischenko, Ivan ;
Seeliger, Hendrik ;
Kleespies, Axel ;
Angele, Martin K. ;
Eichhorn, Martin E. ;
Jauch, Karl-Walter ;
Bruns, Christiane J. .
LANGENBECKS ARCHIVES OF SURGERY, 2010, 395 (01) :1-10
[13]   Trastuzumab (herceptin) targets gastric cancer stem cells characterized by CD90 phenotype [J].
Jiang, J. ;
Zhang, Y. ;
Chuai, S. ;
Wang, Z. ;
Zheng, D. ;
Xu, F. ;
Zhang, Y. ;
Li, C. ;
Liang, Y. ;
Chen, Z. .
ONCOGENE, 2012, 31 (06) :671-682
[14]   NOTCH SIGNALING IN SOLID TUMORS [J].
Koch, Ute ;
Radtke, Freddy .
NOTCH SIGNALING, 2010, 92 :411-+
[15]   Gastric cancer cell growth and epithelial-mesenchymal transition are inhibited by γ-secretase inhibitor DAPT [J].
Li, Lu-Chun ;
Peng, Yang ;
Liu, Yan-Mim ;
Wang, Lu-Lu ;
Wu, Xiao-Ling .
ONCOLOGY LETTERS, 2014, 7 (06) :2160-2164
[16]  
Oh P, 2013, CELL STEM CELL, V13, P190, DOI 10.1016/j.stem.2013.05.015
[17]   Epithelial Mesenchymal Transition and Pancreatic Tumor Initiating CD44+/EpCAM+ Cells Are Inhibited by γ-Secretase Inhibitor IX [J].
Palagani, Vindhya ;
El Khatib, Mona ;
Kossatz, Uta ;
Bozko, Przemyslaw ;
Mueller, Martin R. ;
Manns, Michael P. ;
Krech, Till ;
Malek, Nisar P. ;
Plentz, Ruben R. .
PLOS ONE, 2012, 7 (10)
[18]   Targeting Notch to Target Cancer Stem Cells [J].
Pannuti, Antonio ;
Foreman, Kimberly ;
Rizzo, Paola ;
Osipo, Clodia ;
Golde, Todd ;
Osborne, Barbara ;
Miele, Lucio .
CLINICAL CANCER RESEARCH, 2010, 16 (12) :3141-3152
[19]  
Piazzi G, 2011, ONCOTARGET, V2, P1291
[20]   Identification and expansion of human colon-cancer-initiating cells [J].
Ricci-Vitiani, Lucia ;
Lombardi, Dario G. ;
Pilozzi, Emanuela ;
Biffoni, Mauro ;
Todaro, Matilde ;
Peschle, Cesare ;
De Maria, Ruggero .
NATURE, 2007, 445 (7123) :111-115